The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischaemic left ventricular dysfunction.
Sicari R, Ripoli A, Picano E, Borges AC, Varga A, Mathias W, Cortigiani L, Bigi R, Heyman J, Polimeno S, Silvestri O, Gimenez V, Caso P, Severino S, Djordjevic-Dikic A, Ostojic M, Baldi C, Seveso G, Petix N; VIDA (Viability Identification with Dipyridamole Administration) Study Group.
Sicari R, et al. Among authors: baldi c.
Eur Heart J. 2001 May;22(10):837-44. doi: 10.1053/euhj.2000.2322.
Eur Heart J. 2001.
PMID: 11409375
Clinical Trial.